ATXN2 and Abdominal obesity: However, instead of a neurodegenerative phenotype, ATXN2-deficient rodents exhibited phenotypes characterized by abdominal obesity, insulin resistance, and marked hepatosteatosis (i.e. lipid accumulation in the liver) [45].